143 related articles for article (PubMed ID: 6677110)
1. [Tissue polypeptide antigen (TPA) in urological malignancies. I. S-TPA in bladder cancer patients].
Akiyama T; Tsujihashi H; Boku E; Nagai N; Matsuura T; Iguchi M; Yachiku S; Kurita T
Hinyokika Kiyo; 1983 Dec; 29(12):1635-40. PubMed ID: 6677110
[TBL] [Abstract][Full Text] [Related]
2. [Serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Matsushima M; Kuwabara T; Miyamae K; Hachiya A; Kawahara M; Fukasawa K; Yagishita T; Tajima M; Sawamura Y; Shirai M
Hinyokika Kiyo; 1984 Jul; 30(7):869-75. PubMed ID: 6507205
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
4. [The clinical significance of serum tissue polypeptide antigen as a tumor marker for urogenital carcinomas--a comparison with other tumor markers in patients with renal cell carcinoma and prostatic carcinoma].
Yamazaki K; Kumamoto Y; Tsukamoto T; Umehara T; Ohmura K
Hinyokika Kiyo; 1987 Oct; 33(10):1581-9. PubMed ID: 2451408
[TBL] [Abstract][Full Text] [Related]
5. Serum tissue polypeptide antigen (TPA) as tumor marker for bladder cancer.
van Poppel H; Billen J; Goethuys H; Elgamal AA; Gerits M; Mortelmans L; Blanckaert N; Baert L
Anticancer Res; 1996; 16(4B):2205-7. PubMed ID: 8694544
[TBL] [Abstract][Full Text] [Related]
6. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit].
Sakahara H; Endo K; Torizuka K; Itoh K; Ohuchi N; Inaba N; Miyaji Y; Takayama M; Ishii K; Takagi H; Konishi J; Fukuoka M; Fukuchi M; Ohkawa J; Kagawa S; Kondo S; Shirouzu K; Iguchi H
Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025
[TBL] [Abstract][Full Text] [Related]
7. [Tissue polypeptide antigen in serum and tissue in patients with lung cancer].
Haga E
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):595-604. PubMed ID: 2170727
[TBL] [Abstract][Full Text] [Related]
8. Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage.
Salvati F; Antilli A; Cruciani AR; Pau F; Flore F; Munno R; De Angelis G; Cipri A; Pigorini F
Cancer Detect Prev; 1985; 8(1-2):111-4. PubMed ID: 4064030
[TBL] [Abstract][Full Text] [Related]
9. [Clinical studies on the measurement of urinary tissue polypeptide antigen (TPA) levels using Prolifigen TPA kit "Daiichi"-II in urothelial cancers].
Ohmori H; Ohashi T; Aso Y; Kumamoto Y; Hisazumi H; Shiraiwa Y; Kurita T; Shimazaki J; Ohkawa T; Ogawa H
Hinyokika Kiyo; 1988 Dec; 34(12):2101-10. PubMed ID: 3071123
[TBL] [Abstract][Full Text] [Related]
10. [Serum and urinary tissue polypeptide antigen (TPA) in patients with urological cancer].
Kazama T; Katayama T; Yamazaki N
Hinyokika Kiyo; 1985 Dec; 31(12):2113-9. PubMed ID: 3832915
[TBL] [Abstract][Full Text] [Related]
11. Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancer.
Ecke TH; Lenk SV; Schlechte HH; Loening SA
Anticancer Res; 2003; 23(2A):957-62. PubMed ID: 12820330
[TBL] [Abstract][Full Text] [Related]
12. [Tissue polypeptide antigen as a tumor marker for gynecologic malignancies].
Inoue M; Fujita Y; Abe Y; Inoue Y; Ueda G; Tanizawa O; Minagawa J; Yamada T; Ohashi K; Ozaki M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1799-805. PubMed ID: 4056529
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
14. Tissue polypeptide antigen in the follow-up of patients with urinary bladder cancer compared with conventional urine cytology.
Bantis A; Zissimopoulos A; Sountoulides P; Giannakopoulos S; Kalaitzis C; Athanassiadou P; Agelonidou E; Touloupidis S
Hell J Nucl Med; 2010; 13(3):213-7. PubMed ID: 21193872
[TBL] [Abstract][Full Text] [Related]
15. [The clinical significance of tissue polypeptide antigen (TPA) in the patients with gynecologic tumor].
Inoue M; Inoue Y; Hiramatsu K; Tanaka Y; Yamasaki M; Ueda G; Minagawa J; Ozaki M; Yanagida T; Nishino H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 May; 36(5):779-84. PubMed ID: 6736725
[TBL] [Abstract][Full Text] [Related]
16. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
[TBL] [Abstract][Full Text] [Related]
17. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L
Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169
[TBL] [Abstract][Full Text] [Related]
18. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
Pan QR; Zhang X; Xu ZF; Zheng S
Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
[TBL] [Abstract][Full Text] [Related]
19. Four tumour markers for urinary bladder cancer--tissue polypeptide antigen (TPA), HER-2/neu (ERB B2), urokinase-type plasminogen activator receptor (uPAR) and TP53 mutation.
Ecke TH; Schlechte HH; Schulze G; Lenk SV; Loening SA
Anticancer Res; 2005; 25(1B):635-41. PubMed ID: 15816639
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors.
Giannopoulos A; Manousakas T; Gounari A; Constantinides C; Choremi-Papadopoulou H; Dimopoulos C
J Urol; 2001 Aug; 166(2):470-5. PubMed ID: 11458049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
